The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Stemregen® Names Ryan Riley As Chief Executive Officer, Christian Drapeau As Chief Science Officer
PRIVATEApr 25, 2024•about 2 years ago
Position
Chief Science Officer
Company
STEMREGEN®
Christian Drapeau
AustinBiotechnologyHealth Care
Description
STEMREGEN® announces leadership team changes aligned around the company's business objectives and growth trajectory. Christian Drapeau, the neurophysiology scientist and founder, will become Chief Science Officer to focus on the brand's cutting-edge stem cell research. Ryan Riley, former CEO of Microbe Formulas and CellCore Biosciences, will succeed Drapeau as CEO.
Company Information
Company
STEMREGEN®
Location
Austin, Texas, United States
About
Stemregen creates supplements containing plant extracts sourced from around the globe that have been documented to naturally increase the number of circulating stem cells in the human body. Its core product includes Stemberry™; a sea buckthorn berry extract, Stemaloe™; a proprietary complex with aloe from a unique source, and other ingredients. One serving of two capsules was documented to trigger the release of an average of 10 million additional stem cells from bone marrow to help support the body's innate repair system, paving the way for healthy aging with optimal health and longevity.